Sonic Incytes Medical Corp. Successfully Completes Series A Raise Of Us$7.3M To Accelerate Velacur™ Commercialization
Sonic Incytes Medical Corp. Successfully Completes Series A Raise Of Us$7.3M To Accelerate Velacur™ Commercialization
12/07/21, 10:00 AM
Location
vancouverRound Type
series a
Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M Series A with backing from Nimbus Synergies as the lead investor, and support from Nicola Wealth, Mint Venture Partners, Consortium Medteq, Wavemaker Three-Sixty Health, Gaingels and INP Capital, as well as notable angel investors.